stockrow
Friday 6 November 2026
Export NHC’s income statement to Excel — free account
National HealthCare Corporation
NHC Healthcare Medical Care Facilities
National HealthCare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 16.1% from fiscal 2024.
- Revenue
- +6.61%
- EPS
- −65.6%
- Free cash flow
- +75.5%
- Total debt
- +216.7%
Quarter to September 2026, against a year earlier
207.47
4.93
−2.32%
Follow NHC
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
17.69 | 20.04 | 23.43 | 29.82 |
P/S ratio |
1.40 | 1.63 | 2.12 | 2.17 | |
P/FCF ratio |
14.27 | 14.74 | 22.53 | 19.13 | |
P/Operating CF |
126.20 | 39.69 | 76.29 | 34.62 | |
P/B ratio |
1.97 | 2.26 | 2.93 | 3.03 | |
Price to Tangible BV |
2.40 | 2.74 | 3.52 | 3.65 | |
EV/Sales |
1.24 | 1.47 | 1.99 | 2.06 | |
EV/EBITDA |
10.88 | 12.79 | 16.32 | 17.10 | |
EV/Operating CF |
10.18 | 10.77 | 16.46 | 14.68 | |
EV/FCF |
12.68 | 13.32 | 21.21 | 18.14 | |
Quick Ratio |
1.77 | 1.79 | 1.71 | 0.46 | |
Current Ratio |
1.82 | 1.86 | 1.86 | 1.48 | |
Net Debt/EBITDA |
(6.72) | (7.10) | (4.42) | 0.00 | |
Debt/Assets |
0.49% | 0.00% | 0.00% | 1.15% | |
Debt/Equity |
0.01 | 0.00 | 0.00 | 0.02 | |
Asset Turnover |
1.00 | 0.99 | 1.01 | 0.87 | |
Operating CF/Net income |
0.68 | 1.74 | 1.07 | 7.27 | |
Capex/Depreciation |
(0.88) | (0.83) | (1.12) | 0.00 | |
Interest Coverage |
40.58 | 119.90 | 3,764.23 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
85.23% | 85.46% | 82.44% | 86.13% | |
Intangible Assets out of Total Assets |
0.12 | 0.12 | 0.12 | 0.09 | |
Share Based Compensation of Revenue |
0.23% | 0.34% | 0.49% | 0.49% | |
Graham Net Nets |
0.00 | 0.02 | 0.01 | (0.15) | |
Graham Number |
110.05 | 112.48 | 121.07 | 109.45 | |
Earnings Yield |
5.65% | 4.99% | 4.27% | 3.35% | |
Free Cash Flow Yield |
7.01% | 6.78% | 4.44% | 5.23% | |
Revenue per Share |
24.98 | 24.57 | 26.13 | 26.09 | |
Operating CF per Share |
1.09 | 4.02 | 2.77 | 6.34 | |
Capex per Share |
(0.67) | (0.62) | (0.80) | 0.00 | |
Free Cash Flow per Share |
0.41 | 3.40 | 1.97 | 6.34 | |
Cash per Share |
19.98 | 20.05 | 17.02 | 0.00 | |
Shareholders Equity per Share |
69.45 | 70.56 | 72.23 | 72.33 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
69.45 | 70.56 | 72.23 | 72.33 | |
Free Cash Flow |
6.41 | 52.89 | 30.74 | 99.15 | |
Working Capital |
208.19 | 214.75 | 203.49 | 135.91 | |
Capital Expenditures |
(10.40) | (9.64) | (12.53) | — | |
Net Current Asset Value |
9.92 | 38.10 | 30.73 | (517.15) | |
EV/EBIT |
14.69 | 17.28 | 21.48 | 22.51 | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.00 | |
Price to Operating Income |
16.53 | 19.12 | 22.82 | 23.73 | |
| Other line items | |||||
Average Receivables |
137.16 | 139.74 | 139.88 | 131.10 | |
Average Payables |
24.13 | 21.51 | 21.51 | 22.50 | |
Average Inventory |
8.42 | 8.61 | 8.21 | 8.25 | |
Average Assets |
1,525.42 | 1,536.46 | 1,549.58 | 1,820.17 | |
Average Common Equity |
1,028.84 | 1,052.30 | 1,076.72 | 1,094.72 |
Columns are period end dates · fundamentals updated 5 Nov 2026